There are a whole bunch of small pharmaceutical companies that are just kind of getting started right now. What this company is doing so far is good. To grow in this world right now, because the acquisition world is so hot, it is hard to find stuff. What you have to do now is get product rights and slowly develop them over time. His guess on this one is that this will be a good, long term holding, but there might be more interesting places to be in the short term. (See Top Picks.)
Tribute Pharmaceuticals Canada Inc is a OTC stock, trading under the symbol ARZ-T on the (). It is usually referred to as or ARZ-T
In the last year, there was no coverage of Tribute Pharmaceuticals Canada Inc published on Stockchase.
Tribute Pharmaceuticals Canada Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Tribute Pharmaceuticals Canada Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Tribute Pharmaceuticals Canada Inc published on Stockchase.
On , Tribute Pharmaceuticals Canada Inc (ARZ-T) stock closed at a price of $.
Quite expensive at about 13X EBITDA. He would much prefer Merus (MSL-T) than this.